Resources
77 Results (showing 1 - 10)
Results sorted by posted date (newest first)
Results sorted by posted date (newest first)
Posted 3/10/2024 (updated 3/28/2024)
The Substance Abuse and Mental Health Services Administration's (SAMHSA) updated Overdose Prevention and Response Toolkit provides guidance to a wide range of individuals on preventing and responding to an overdose. It emphasizes harm reduction and access to treatment as essential aspects of overdose prevention.
Posted 2/9/2024 (updated 3/28/2024)
The U.S. Department of Health and Human Services, through its Office for Civil Rights (OCR) and the Substance Abuse and Mental Health Services Administration (SAMHSA), finalized modifications to the Confidentiality of Substance Use Disorder (SUD) Patient Records regulations at 42 CFR part 2 (“Part 2”), which protect the privacy of patients’ SUD treatment records.
Posted 12/1/2023 (updated 3/28/2024)
The Substance Abuse and Mental Health Services Administration (SAMHSA) released results of the 2022 National Survey on Drug Use and Health (NSDUH). The NSDUH provides information on substance use and mental health rates in the United States with data on the self-reported use of tobacco, alcohol, and illicit drugs; substance use disorders; mental health conditions; and suicidal thoughts and behaviors. SAMSHA also released a high-level brief of the report with infographics.
Posted 11/17/2023 (updated 3/28/2024)
Celebrate and honor the culture, traditions, and achievements of the nation's original inhabitants and of their descendants. The U.S Department of Health and Human Services (HHS) and the HHS Office of Minority Health (OMH) honor the history, culture, and legacy of Tribal nations and Indigenous communities across the United States.
Posted 9/25/2023 (updated 3/27/2024)
The U.S. Department of Health and Human Services (HHS) has now added American Sign Language (ASL) services to the 988 Suicide and Crisis Lifeline. An ongoing effort of the HHS is to expand accessibility to behavioral health care for underserved communities, which includes individuals who are Deaf and Hard of Hearing.
Posted 9/5/2023 (updated 3/26/2024)
Visit the Substance Abuse and Mental Health Services Administration (SAMHSA) to learn more about National Recovery Month, held every September. National Recovery Month is dedicated to promoting and supporting new evidence-based treatment and recovery practices. Find events, read President Biden's proclamation on National Recovery month, and discover many resources which can be utilized in your organization and community.
Posted 9/4/2023 (updated 3/26/2024)
The Substance Abuse and Mental Health Services Administration (SAMHSA) has created a toolkit for National Recovery Month 2023 to support people in recovery from mental and substance use disorders. The toolkit includes social media content material, resources for recovery, and recovery promotional materials.
Posted 4/26/2023 (updated 3/27/2024)
HRSA and JBS have developed guidance to assist your RCORP data collection and Performance Improvement Measurement System (PIMS) reporting efforts. This page contains the RCORP data collection resources for the Behavioral Health Care Support grantees.
Posted 4/26/2023 (updated 3/27/2024)
HRSA and JBS have developed guidance to assist your RCORP data collection and Performance Improvement Measurement System (PIMS) reporting efforts. This page contains the RCORP data collection resources for the MAT Access grantees.
Posted 12/21/2022 (updated 3/27/2024)
The Substance Abuse and Mental Health Services Administration released a notice of proposed rulemaking that would allow certified opioid treatment programs to begin prescribing the drug via audio-only or video-enabled telehealth. See additional information under Policy Updates below. The proposed changes come on top of recent findings by HHS of the positive impact of its revised Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder that removed two longstanding requirements for obtaining a waiver to treat up to 30 patients with buprenorphine: 1) the requirement for specific training, and 2) the need for otherwise eligible clinicians to certify their ability to provide or refer patients for counseling and other services. Rural primary care providers have obtained the DEA waiver at a lower rate than urban clinicians; decreased burden and greater flexibility in the guidelines, along with broader use of telehealth could help close that gap.